Qbrexza

Active Ingredient(s): Glycopyrronium Tosylate
FDA Approved: * June 28, 2018
Pharm Company: * DERMIRA INC
Category: Anticholinergic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Qbrexza Overview

Glycopyrronium bromide is a medication of the muscarinic anticholinergic group. It does not cross the blood–brain barrier and consequently has no to few central effects. It is available in by mouth, intravenous, and inhalated forms. It is a synthetic quaternary amine. It was developed by Sosei and licensed to Novartis in 2005. The cation, which is the active moiety, is called glycopyrronium (INN)[1] or glycopyrrolate (USAN). In June 2018, glycopyrronium was approved by ...

Read more Qbrexza Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Glycopyrronium_bromide

Recent Qbrexza Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Glycopyrronium Tosylate
  • Cloth: 2.4%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Qbrexza: (1 result)

Sorted by National Drug Code
  • 70428-011 Qbrexza 2.4 g/100g Topical Cloth by Dermira, Inc.

Other drugs which contain Glycopyrronium Tosylate or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 13 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA